
HARP Stock Forecast & Price Target
HARP Analyst Ratings
Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 45%
Hold 27%
Sell 0%
Strong Sell 0%
HARP has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 45% recommend Buy, 27% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.
This aggregate rating is based on analysts' research of Harpoon Therapeutics Inc and is not a guaranteed prediction by Public.com or investment advice.
This aggregate rating is based on analysts' research of Harpoon Therapeutics Inc and is not a guaranteed prediction by Public.com or investment advice.
HARP Analyst Forecast & Price Prediction
Get the latest HARP stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Start investing in HARP
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Harpoon Therapeutics Inc (HARP) Forecast
Analysts have given HARP a Buy based on their latest research and market trends.
According to 11 analysts, HARP has a Buy consensus rating as of Jun 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $20.45, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $20.45, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.